These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7901226)

  • 21. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity.
    Peretz D; Williamson RA; Kaneko K; Vergara J; Leclerc E; Schmitt-Ulms G; Mehlhorn IR; Legname G; Wormald MR; Rudd PM; Dwek RA; Burton DR; Prusiner SB
    Nature; 2001 Aug; 412(6848):739-43. PubMed ID: 11507642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions.
    Wang F; Yang F; Hu Y; Wang X; Wang X; Jin C; Ma J
    Biochemistry; 2007 Jun; 46(23):7045-53. PubMed ID: 17503780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy.
    Veith NM; Plattner H; Stuermer CA; Schulz-Schaeffer WJ; Bürkle A
    Eur J Cell Biol; 2009 Jan; 88(1):45-63. PubMed ID: 18834644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel epitope for the specific detection of exogenous prion proteins in transgenic mice and transfected murine cell lines.
    Vorberg I; Buschmann A; Harmeyer S; Saalmüller A; Pfaff E; Groschup MH
    Virology; 1999 Mar; 255(1):26-31. PubMed ID: 10049818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics of prion diseases and prion diversity in mice.
    Carlson GA; DeArmond SJ; Torchia M; Westaway D; Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):363-9. PubMed ID: 7913753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition.
    Baldwin MA; Pan KM; Nguyen J; Huang Z; Groth D; Serban A; Gasset M; Mehlhorn I; Fletterick RJ; Cohen FE
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):435-41. PubMed ID: 7913763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applicability of three anti-PrP peptide sera including staining of tonsils and brainstem of sheep with scrapie.
    Garssen GJ; Van Keulen LJ; Farquhar CF; Smits MA; Jacobs JG; Bossers A; Meloen RH; Langeveld JP
    Microsc Res Tech; 2000 Jul; 50(1):32-9. PubMed ID: 10871546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion-protein-specific aptamer reduces PrPSc formation.
    Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
    Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal host prion protein necessary for scrapie-induced neurotoxicity.
    Brandner S; Isenmann S; Raeber A; Fischer M; Sailer A; Kobayashi Y; Marino S; Weissmann C; Aguzzi A
    Nature; 1996 Jan; 379(6563):339-43. PubMed ID: 8552188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected].
    Caughey B; Brown K; Raymond GJ; Katzenstein GE; Thresher W
    J Virol; 1994 Apr; 68(4):2135-41. PubMed ID: 7511169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosynthesis of the prion proteins in scrapie-infected cells in culture.
    Taraboulos A; Scott M; Semenov A; Avrahami D; Prusiner SB
    Braz J Med Biol Res; 1994 Feb; 27(2):303-7. PubMed ID: 8081243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells.
    Paquet S; Daude N; Courageot MP; Chapuis J; Laude H; Vilette D
    J Virol; 2007 Oct; 81(19):10786-91. PubMed ID: 17626095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergent heparin-induced fibrillation pathways of a prion amyloidogenic determinant.
    Bazar E; Jelinek R
    Chembiochem; 2010 Sep; 11(14):1997-2002. PubMed ID: 20799315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment.
    Pérez M; Wandosell F; Colaço C; Avila J
    Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):369-74. PubMed ID: 9761736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells.
    Borchelt DR; Scott M; Taraboulos A; Stahl N; Prusiner SB
    J Cell Biol; 1990 Mar; 110(3):743-52. PubMed ID: 1968466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular heparan sulfate participates in the metabolism of prions.
    Ben-Zaken O; Tzaban S; Tal Y; Horonchik L; Esko JD; Vlodavsky I; Taraboulos A
    J Biol Chem; 2003 Oct; 278(41):40041-9. PubMed ID: 12871949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent inhibition of scrapie-associated PrP accumulation by congo red.
    Caughey B; Race RE
    J Neurochem; 1992 Aug; 59(2):768-71. PubMed ID: 1352803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid formation by the model protein muscle acylphosphatase is accelerated by heparin and heparan sulphate through a scaffolding-based mechanism.
    Motamedi-Shad N; Monsellier E; Chiti F
    J Biochem; 2009 Dec; 146(6):805-14. PubMed ID: 19675100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-surface prion protein interacts with glycosaminoglycans.
    Pan T; Wong BS; Liu T; Li R; Petersen RB; Sy MS
    Biochem J; 2002 Nov; 368(Pt 1):81-90. PubMed ID: 12186633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.